SAG
MET icon

SageView Advisory Group’s MetLife MET Stock Holding History

SageView Advisory Group’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$742K Sell
8,769
-167
-2% -$13.5K 0.02% 289
2026
Q1 		$632K Sell
8,936
-941
-10% -$70.5K 0.02% 307
2025
Q4 		$780K Sell
9,877
-799
-7% -$63.2K 0.03% 286
2025
Q3 		$879K Sell
10,676
-776
-7% -$61.1K 0.03% 281
2025
Q2 		$889K Sell
11,452
-215
-2% -$16.6K 0.03% 261
2025
Q1 		$937K Sell
11,667
-605
-5% -$50.3K 0.04% 238
2024
Q4 		$1M Buy
12,272
+374
+3% +$31.1K 0.04% 222
2024
Q3 		$981K Sell
11,898
-941
-7% -$70.3K 0.05% 200
2024
Q2 		$901K Buy
12,839
+8,022
+167% +$573K 0.04% 237
2024
Q1 		$365K Sell
4,817
-12,345
-72% -$860K 0.02% 377
2023
Q4 		$1.22M Buy
17,162
+580
+3% +$36.3K 0.05% 219
2023
Q3 		$1.04M Sell
16,582
-3,592
-18% -$224K 0.06% 205
2023
Q2 		$1.14M Buy
20,174
+110
+0.5% +$6.1K 0.06% 198
2023
Q1 		$1.16M Buy
+20,064
New +$1.35M 0.07% 181

Other funds holding MET

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SageView Advisory Group's MET Position: Q2 2026 in Review

SageView Advisory Group reduced its MetLife (MET) stake by 1.9% in Q2 2026, selling an estimated $13.5K and leaving 8,769 shares worth $742K. The position accounts for 0.02% of the portfolio, ranked #289.

SageView Advisory Group first reported a position in MET in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.22M in Q4 2023. 1,448 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • SageView Advisory Group held 8,769 shares of MetLife worth $742K as of Q2 2026.
  • SageView Advisory Group sold 167 MetLife shares in Q2 2026, an estimated $13.5K.
  • MetLife made up 0.02% of SageView Advisory Group's portfolio in Q2 2026, its #289 holding.
  • SageView Advisory Group first reported a position in MetLife in Q1 2023 and has held it in 14 quarters since.
  • SageView Advisory Group's MetLife position peaked at $1.22M in Q4 2023.
  • 1,448 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.